Hazel M Dockrell
Overview
Explore the profile of Hazel M Dockrell including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
156
Citations
4152
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Lee J, Lacerda E, Kingdon C, Susannini G, Dockrell H, Nacul L, et al.
medRxiv
. 2025 Jan;
PMID: 39830245
Myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) is a debilitating but poorly-understood disease. ME/CFS symptoms can range from mild to severe, and include immune system effects alongside incapacitating fatigue and post-exertional disease...
2.
Martin W, Luis C, Jungbluth S, Slezak M, Verreck F, Spiegel H, et al.
Vaccines (Basel)
. 2025 Jan;
12(12.
PMID: 39772106
TRANSVAC represents a long-running effort to accelerate the development of novel vaccines by integrating institutions from across Europe under a single collaborative framework. This initiative has empowered the global vaccine...
3.
Tarekegn B, Tientcheu L, Decker J, Bell A, Mukamolova G, Kampmann B, et al.
Lancet Microbe
. 2024 Jun;
5(9):100885.
PMID: 38906163
Background: High proportions of Mycobacterium tuberculosis cells in sputum containing triacylglycerol-rich lipid bodies have been shown to be associated with treatment failure or relapse following antituberculous chemotherapy. Although lipid body...
4.
Davies L, Wang C, Steigler P, Bowman K, Fischinger S, Hatherill M, et al.
Nat Microbiol
. 2024 Apr;
9(6):1513-1525.
PMID: 38658786
Antibody features vary with tuberculosis (TB) disease state. Whether clinical variables, such as age or sex, influence associations between Mycobacterium tuberculosis-specific antibody responses and disease state is not well explored....
5.
Impaired resolution of blood transcriptomes through tuberculosis treatment with diabetes comorbidity
Eckold C, van Doorn C, Ruslami R, Ronacher K, Riza A, van Veen S, et al.
Clin Transl Med
. 2023 Aug;
13(9):e1375.
PMID: 37649224
Background: People with diabetes are more likely to develop tuberculosis (TB) and to have poor TB-treatment outcomes than those without. We previously showed that blood transcriptomes in people with TB-diabetes...
6.
Perez-Hernandez C, Moreno-Altamirano M, Lopez-Villegas E, Butkeviciute E, Ali M, Kronsteiner B, et al.
Biology (Basel)
. 2022 Aug;
11(8).
PMID: 36009759
Several intermediate metabolites harbour cell-signalling properties, thus, it is likely that specific metabolites enable the communication between neighbouring cells, as well as between host cells with the microbiota, pathogens, and...
7.
Negera E, Bobosha K, Aseffa A, Dockrell H, Lockwood D, Walker S
PLoS Negl Trop Dis
. 2022 Jul;
16(7):e0010641.
PMID: 35867720
Background: The numbers of circulating regulatory T cells (Tregs) are increased in lepromatous leprosy (LL) but reduced in erythema nodosum leprosum (ENL), the inflammatory complication of LL. It is unclear...
8.
van Doorn C, Eckold C, Ronacher K, Ruslami R, van Veen S, Lee J, et al.
EBioMedicine
. 2022 Jul;
82:104173.
PMID: 35841871
Background: Globally, the tuberculosis (TB) treatment success rate is approximately 85%, with treatment failure, relapse and death occurring in a significant proportion of pulmonary TB patients. Treatment success is lower...
9.
10.
Dockrell H, McShane H
EBioMedicine
. 2022 Apr;
79:103993.
PMID: 35427852
The Mycobacterium bovis BCG vaccine was first used in 1921, but has not controlled the global spread of tuberculosis (TB). There are still no new licensed tuberculosis vaccines, although there...